Ibandronate Sodium Tablet, Film Coated
Product Images NDC 65862-237

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 65862-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (Blister Carton (Three 150 mg Tablets = Three-month supply))

This is a description of a prescription medication called Ibandronate Sodium Tablets. The dosage usually involves taking one tablet once a month. The package contains three tablets which is supposed to be a three-month supply. This medication contains ibandronate sodium monohydrate which is equivalent to 150mg of fres acid. This package is child-resistant. The text also encourages the pharmacist to provide the medication guide alongside the prescription. The manufacturer of the medication is Aurobindo Pharma USA.*

FDA Label Image

Ibandronate Structure (Ibandronate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.